I can't see any reason why they're not marketable commercial propositions. I wouldn't be deeply invested in IMU if I thought otherwise. I've little experience in Big Pharma Oncology. My experience is Cardio/Metabolic/Renal.
However. I do know that BP have been and are currently re-structuring their field forces more towards specialty care recently. Moving away from the Primary care space. Especially into the Oncology space. Big big money in Oncology.
Watch this space is all I can say with any confidence.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |